These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10577070)

  • 21. Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone?
    Scherbaum WA
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):312-3. PubMed ID: 16932451
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
    Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus.
    Füchtenbusch M; Standl E; Schatz H
    Exp Clin Endocrinol Diabetes; 2000; 108(3):151-63. PubMed ID: 10926309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone.
    Goldstein BJ
    Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone and rosiglitazone for diabetes.
    Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A treatment for Mr WP: thiazolidinediones after troglitazone.
    Montague CT
    Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.
    Raskin P; Rendell M; Riddle MC; Dole JF; Freed MI; Rosenstock J;
    Diabetes Care; 2001 Jul; 24(7):1226-32. PubMed ID: 11423507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of troglitazone in type 2 diabetes mellitus.
    Gorson DM
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
    Buch HN; Baskar V; Barton DM; Kamalakannan D; Akarca C; Singh BM
    Diabet Med; 2002 Jul; 19(7):572-4. PubMed ID: 12099960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.
    Ko SH; Song KH; Ahn YB; Yoo SJ; Son HS; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Metabolism; 2003 Jun; 52(6):731-4. PubMed ID: 12800099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes.
    Phillips LS; Grunberger G; Miller E; Patwardhan R; Rappaport EB; Salzman A;
    Diabetes Care; 2001 Feb; 24(2):308-15. PubMed ID: 11213884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of troglitazone in type 2 diabetes mellitus.
    Rusk MH
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656
    [No Abstract]   [Full Text] [Related]  

  • 33. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 34. Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
    Barnett AH; Grant PJ; Hitman GA; Mather H; Pawa M; Robertson L; Trelfa A;
    Diabet Med; 2003 May; 20(5):387-93. PubMed ID: 12752488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
    Dharmalingam M; Kumar P
    J Assoc Physicians India; 2001 Jan; 49 Spec No():46-9. PubMed ID: 11235605
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.
    Freed MI; Ratner R; Marcovina SM; Kreider MM; Biswas N; Cohen BR; Brunzell JD;
    Am J Cardiol; 2002 Nov; 90(9):947-52. PubMed ID: 12398960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.
    Khan MA; St Peter JV; Xue JL
    Diabetes Care; 2002 Apr; 25(4):708-11. PubMed ID: 11919129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2000 Jun; 2(3):139-47. PubMed ID: 11220549
    [No Abstract]   [Full Text] [Related]  

  • 39. Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C.
    Zhu XX; Pan CY; Li GW; Shi HL; Tian H; Yang WY; Jiang J; Sun XC; Davies C; Chow WH
    Diabetes Technol Ther; 2003; 5(1):33-42. PubMed ID: 12725705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus.
    Reynolds LR; Konz EC; Frederich RC; Anderson JW
    Diabetes Obes Metab; 2002 Jul; 4(4):270-5. PubMed ID: 12099976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.